Abeona Therapeutics (ABEO) Assets Average (2011 - 2026)

Abeona Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $209.0 million for Q1 2026.

• In Q1 2026, Assets Average rose 100.71% year-over-year to $209.0 million; the TTM figure through Mar 2026 stood at $209.0 million (up 100.71% YoY), while the FY2025 annual figure was $164.3 million, up 89.96% from the prior year.
• Assets Average was $209.0 million for Q1 2026 at Abeona Therapeutics, down from $225.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $238.7 million in Q3 2025 to a low of $41.7 million in Q3 2022.
• Historically, Assets Average has averaged $106.7 million across 5 years, with a median of $69.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets Average tumbled 66.57% in 2022, then soared 112.81% in 2024.
• A 5-year view of Assets Average shows it stood at $51.5 million in 2022, then rose by 26.33% to $65.0 million in 2023, then soared by 76.44% to $114.8 million in 2024, then soared by 96.35% to $225.3 million in 2025, then declined by 7.23% to $209.0 million in 2026.
• The last three Assets Average figures came in at $209.0 million (Q1 2026), $225.3 million (Q4 2025), and $238.7 million (Q3 2025), per Business Quant data.